Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Resources Limited Regulatory News (FAR)

Share Price Information for Ferro-alloy Resources Limited (FAR)

Share Price is delayed by 15 minutes
Get Live Data
5.00    0.00 (0.00%)
Bid:
4.90
Ask:
5.10
Spread: 0.20 (4.082%)
Market Cap: £29.39m
FAR Live PriceLast checked at - London Stock Exchange

Intraday Ferro-alloy Resources Limited Share Chart

Re Contract

4 Jan 2006 16:26

Farsight PLC04 January 2006 Farsight Grows Revenues Farsight plc announces that it has acquired existing contracts for the provisionof 24 hour CCTV monitoring. The contracts have between 12 and 36 months beforethey fall due for renewal and the revenue they bring to Farsight is £276,000 perannum. Farsight has paid £55,000 for the contracts, satisfied by the issue to thevendor of 5.5 million ordinary shares in Farsight at 1p per share. Additionalconsideration may become payable at the beginning of 2008 if the revenue earnedby Farsight from the parties to the contracts increases. Such additionalconsideration is not expected to exceed £50,000 and not less than 75% of suchconsideration would be satisfied again through the issue of ordinary shares inFarsight. Application will be made for the 5.5 million consideration shares to be admittedto AIM and it is expected that admission will take place on 11 January 2006. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 20267:00 amRNSNon-Executive Director Share Sale
1st May 20267:00 amRNSGrant of Share Options
30th Apr 20267:00 amRNS2025 Final Results
1st Apr 20267:00 amRNSTotal Voting Rights & Admission of Shares
10th Mar 20267:00 amRNSIssue of Equity
19th Jan 20267:00 amRNSCarbon Black Substitute MOU
5th Dec 20257:00 amRNSIssue of Equity
14th Nov 20254:55 pmRNSResult of 2025 AGM
5th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:17 amRNSProject Finance Expression of Interest
13th Oct 20257:00 amRNSPositive Feasibility Study Results
9th Oct 20257:00 amRNSNotice of AGM
30th Sep 20257:00 amRNSInterim Results and feasibility study update
7th Jul 20257:00 amRNSIssue of Equity
27th Jun 20257:00 amRNSCBS Product Update and Feasibility Study Update
23rd Jun 20257:00 amRNSAppointment of Lead Financial Adviser
2nd Jun 20257:00 amRNSFramework Agreement for Phase 1 of Balasausqandiq
2nd May 20257:00 amRNSGrant of Share Options
30th Apr 20257:00 amRNS2024 Final Results
6th Mar 20257:00 amRNSIssue of Equity to Supplier
19th Dec 202412:10 pmRNSIssue of Equity to Directors & Share Subscription
17th Dec 20247:00 amRNSNon-Binding Offtake Term Sheet for Balasausqandiq
2nd Dec 20247:00 amRNSStrategic Focus on Carbon Black Substitute
29th Nov 20247:00 amRNSKazakhstan Exempt Offer Bond Programme Update
21st Nov 20247:00 amRNSCommercial Potential of Carbon Black Substitute
24th Oct 20247:00 amRNSQ3 2024 Production Results
23rd Oct 20244:52 pmRNSResult of 2024 AGM
26th Sep 20247:00 amRNSInterim Results
19th Sep 20247:00 amRNSNotice of AGM
18th Jul 20247:00 amRNSQ2 2024 Production Results
29th Apr 20247:00 amRNSFinal Results
26th Apr 20247:00 amRNSQ1 2024 Production Results
15th Feb 20241:00 pmRNSSale of 3rd Tranche of Exempt Offer Bond Programme
1st Feb 20247:00 amRNSFeasibility Study Update & Bond Programme
12th Jan 20247:00 amRNSQ4 2023 Production Results
22nd Dec 20237:00 amRNSTrading Update
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSHolding(s) in Company
21st Nov 202312:17 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSIssue of Equity
1st Nov 20235:08 pmRNSResult of AGM
17th Oct 20237:00 amRNSExempt Offer Bond Programme - Second Tranche Sale
10th Oct 202312:53 pmRNSExisting Operation Q3 Production Results
6th Oct 20237:00 amRNSNotice of AGM
19th Sep 20237:00 amRNSExempt Offer Bond Programme - Second Tranche
12th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSGrant of Share Options
11th Sep 20237:00 amRNSHalf-year Report
21st Aug 20237:00 amRNSTrading Update
27th Jul 20239:00 amRNSLaunch of Bond Programme /Listing of First Tranche

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.